Artificial Intelligence In Drug Discovery And Development Ebook Tooltip

Afbeeldingen

Inkijkexemplaar

Artikel vergelijken

  • Engels
  • E-book
  • 9798223603863
  • 31 mei 2023
  • Epub zonder kopieerbeveiliging (DRM)
Alle productspecificaties
  • Je leest ebooks gemakkelijk op je Kobo e-reader, of op je smartphone of tablet met de bol.com Kobo app. Let op! Ebooks kunnen niet geannuleerd of geretourneerd worden.

Samenvatting

Artificial intelligence (AI) is a simulation of the process of human intelligence through computers.

AI has cemented its status as a powerful technology with the ability to propel a paradigm shift in healthcare and medicine of the 21st century and the future. The insights and values gained from AI and its subset, machine learning, are essential for predicting health outcomes and improving decision-making in healthcare and medicine.

AI can offer revolutionary insights into medicine, through data from genetics, proteomics and other life sciences that advance the process of drug discovery and development. Discovering drugs is a crucial first step in the biopharmaceutical value chain. Drug discovery is a long, expensive and often unsuccessful process. The biopharmaceutical industry makes efforts to employ AI to improve drug discovery, reduce research and development costs, reduce the time and cost of early drug discovery, and support predicting potential risks/side effects in late clinical trials that can be useful in avoiding traumatic events in clinical trials.

The rapid growth in life sciences and machine learning algorithms has led to enormous statistical access to the growth of AI-based start-ups focused on drug innovation in recent years. The growing need to curb drug discovery costs and reduce time involved in the drug development process, the rising adoption of cloud-based applications and services, and the impending patent expiry of blockbuster drugs are some of the key factors driving the growth of this market.

However, shortage of AI workforce and ambiguous regulatory guidelines for medical software and lack of data sets in this field are some of the factors expected to restrain the growth of this market in the coming years.

Productspecificaties

Inhoud

Taal
en
Bindwijze
E-book
Oorspronkelijke releasedatum
31 mei 2023
Ebook Formaat
Epub zonder kopieerbeveiliging (DRM)

Betrokkenen

Hoofdauteur
Mbuso Mabuza

Lees mogelijkheden

Lees dit ebook op
Android (smartphone en tablet) | Kobo e-reader | Desktop (Mac en Windows) | iOS (smartphone en tablet) | Windows (smartphone en tablet)

Overige kenmerken

Studieboek
Nee

EAN

EAN
9798223603863

Je vindt dit artikel in

Taal
Engels
Beschikbaarheid
Leverbaar
Beschikbaar in Kobo Plus
Beschikbaar in Kobo Plus
Boek, ebook of luisterboek?
Ebook
Nog geen reviews

Kies gewenste uitvoering

Prijsinformatie en bestellen

De prijs van dit product is 9 euro en 49 cent.
Direct beschikbaar
Verkoop door bol
  • E-book is direct beschikbaar na aankoop
  • E-books lezen is voordelig
  • Dag en nacht klantenservice
  • Veilig betalen
Houd er rekening mee dat je downloadartikelen niet kunt annuleren of retourneren. Bij nog niet verschenen producten kun je tot de verschijningsdatum annuleren.
Zie ook de retourvoorwaarden